![]() |
Name |
[(1R,2R,3Z,5R,7S,9Z,11R,12S,15R,16S)-16-benzyl-5,12-dihydroxy-5,7,13,14-tetramethyl-18-oxo-17-azatricyclo[9.7.0.01,15]octadeca-3,9,13-trien-2-yl] acetate
|
Molecular Formula | C30H39NO5 | |
IUPAC Name* |
[(1R,2R,3Z,5R,7S,9Z,11R,12S,15R,16S)-16-benzyl-5,12-dihydroxy-5,7,13,14-tetramethyl-18-oxo-17-azatricyclo[9.7.0.01,15]octadeca-3,9,13-trien-2-yl] acetate
|
|
SMILES |
C[C@H]1C/C=C\[C@H]2[C@@H](C(=C([C@@H]3[C@@]2([C@@H](/C=C\[C@](C1)(C)O)OC(=O)C)C(=O)N[C@H]3CC4=CC=CC=C4)C)C)O
|
|
InChI |
InChI=1S/C30H39NO5/c1-18-10-9-13-23-27(33)20(3)19(2)26-24(16-22-11-7-6-8-12-22)31-28(34)30(23,26)25(36-21(4)32)14-15-29(5,35)17-18/h6-9,11-15,18,23-27,33,35H,10,16-17H2,1-5H3,(H,31,34)/b13-9-,15-14-/t18-,23-,24-,25+,26-,27+,29-,30+/m0/s1
|
|
InChIKey |
WFSYATBEJTUDQA-XMFKKRFLSA-N
|
|
Synonyms |
cytochalasin n; NCGC00247577-01
|
|
CAS | NA | |
PubChem CID | 53316351 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 493.6 | ALogp: | 2.8 |
HBD: | 3 | HBA: | 5 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 95.9 | Aromatic Rings: | 4 |
Heavy Atoms: | 36 | QED Weighted: | 0.425 |
Caco-2 Permeability: | -5.244 | MDCK Permeability: | 0.00001350 |
Pgp-inhibitor: | 0.169 | Pgp-substrate: | 0.997 |
Human Intestinal Absorption (HIA): | 0.067 | 20% Bioavailability (F20%): | 0.698 |
30% Bioavailability (F30%): | 0.634 |
Blood-Brain-Barrier Penetration (BBB): | 0.265 | Plasma Protein Binding (PPB): | 89.51% |
Volume Distribution (VD): | 1.027 | Fu: | 7.21% |
CYP1A2-inhibitor: | 0.03 | CYP1A2-substrate: | 0.111 |
CYP2C19-inhibitor: | 0.819 | CYP2C19-substrate: | 0.77 |
CYP2C9-inhibitor: | 0.785 | CYP2C9-substrate: | 0.264 |
CYP2D6-inhibitor: | 0.122 | CYP2D6-substrate: | 0.182 |
CYP3A4-inhibitor: | 0.906 | CYP3A4-substrate: | 0.45 |
Clearance (CL): | 6.681 | Half-life (T1/2): | 0.883 |
hERG Blockers: | 0.231 | Human Hepatotoxicity (H-HT): | 0.927 |
Drug-inuced Liver Injury (DILI): | 0.37 | AMES Toxicity: | 0.069 |
Rat Oral Acute Toxicity: | 0.257 | Maximum Recommended Daily Dose: | 0.793 |
Skin Sensitization: | 0.156 | Carcinogencity: | 0.02 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.009 |
Respiratory Toxicity: | 0.856 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004463 | ![]() |
0.818 | D06CWH | ![]() |
0.286 | ||
ENC003169 | ![]() |
0.810 | D0V3ZA | ![]() |
0.269 | ||
ENC004468 | ![]() |
0.768 | D0SP3D | ![]() |
0.268 | ||
ENC005134 | ![]() |
0.739 | D05VQI | ![]() |
0.262 | ||
ENC003653 | ![]() |
0.724 | D01TSI | ![]() |
0.261 | ||
ENC002261 | ![]() |
0.724 | D09NNH | ![]() |
0.261 | ||
ENC001922 | ![]() |
0.719 | D0O5WP | ![]() |
0.261 | ||
ENC002762 | ![]() |
0.701 | D0D7KC | ![]() |
0.257 | ||
ENC002174 | ![]() |
0.693 | D0TB8C | ![]() |
0.257 | ||
ENC003331 | ![]() |
0.675 | D0C4RB | ![]() |
0.250 |